CMV infection among HIV / AIDS patients in Iraq
Background : The aim of the study was to determine the prevalence of CMV infection among HIV / AIDS patients in relation to disease progression, and to study the mortality during the period of the study. Patients and Methods : The study included 155 HIV/AIDS patients (148 HIV-infected and seven AIDS...
Gespeichert in:
Veröffentlicht in: | Journal of the Faculty of Medicine, Baghdad Baghdad, 2006, Vol.48 (4), p.407-409 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background : The aim of the study was to determine the prevalence of CMV infection among HIV /
AIDS patients in relation to disease progression, and to study the mortality during the period of the
study.
Patients and Methods : The study included 155 HIV/AIDS patients (148 HIV-infected and seven AIDS
patients) and 122 apparently "healthy" controls. CMV (IgG and 1gM) antibodies were determined by
ELISA. The patients were followed up for a period of nine months, and retested frequently for
development of active CMV infection.
Results : The prevalence of CMV (IgG) antibodies in the HIV/AIDS patients was 100 %. A significant
higher prevalence of CMV (IgM) among AIDS patients (42.9° / 6) than among HIV infected patients
(0.0%) and "healthy" controls (0. 8 %). No deaths were reported among asymptomatic HIV
infected patients while the mortality among AIDS patients was (42. 9 %). Only one patient (7. 7 %)
out of 13 asymptomatic HIV infected developed active CMV infection 10 years later by
testing for CMV (IgM) in 1991 and 2001.
Conclusion : Demonstration of active CMV is of prognostic value in detection of development
of AIDS and survival of patients. |
---|---|
ISSN: | 0041-9419 2410-8057 |